Trypsinogen variants in pancreatic juice of healthy volunteers, chronic alcoholics, and patients with pancreatitis and cancer of the pancreas

H. Rinderknecht, I. G. Renner and C. Carmack

Polyacrylamide gel electrophoresis of pure pancreatic juice from 14 healthy normal subjects, 11 chronic alcoholics without detectable pancreatic disease, 15 patients with pancreatitis, and two with cancer of the pancreas consistently demonstrated the presence of two variants of trypsinogen with different electrophoretic mobilities. In healthy normal subjects the proportion of cationic to anionic trypsinogen was invariably greater than 1 and averaged about 2. In chronic alcoholics, patients with pancreatitis or cancer of the pancreas, this ratio, with a single exception, was below one and averaged about 0·45. The extraordinary consistency of these findings suggests that the quantitative relationship between cationic and anionic trypsinogen in human pancreatic juice may be a very sensitive indicator of incipient or existing pancreatic pathology. The most acceptable explanation for the reversal of the normal zymogen ratio in pancreatic disease is a selective increase in the synthesis of the anionic variant relative to that of the cationic species. Total trypsinogen concentrations differed widely from one another in the three patient groups, but the ratio of cationic to anionic trypsinogen exhibited little change and remained below 1. Our results also demonstrate for the first time a specific effect of chronic alcohol abuse on the secretory profile of a pancreatic enzyme in human subjects. A newly discovered minor, trypsinogen-like component of human pancreatic juice was found to be significantly increased in pancreatic juice of chronic alcoholics, decreased in pancreatic secretions of patients with pancreatitis, and barely detectable in those of two patients with cancer of the pancreas.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Weiss, F. U., Sahin-Toth, M. (2009). Variations in trypsinogen expression may influence the protective effect of the p.G191R PRSS2 variant in chronic pancreatitis. Gut 58: 749-750 [Full Text]  
• Kume, K, Masamune, A, Takagi, Y, Kikuta, K, Watanabe, T, Satoh, K, Satoh, A, Hirota, M, Hamada, S, Shimosegawa, T (2009). A loss-of-function p.G191R variant in the anionic trypsinogen (PRSS2) gene in Japanese patients with pancreatic disorders. Gut 58: 820-824 [Abstract] [Full Text]  
• Szmola, R., Sahin-Toth, M. (2007). Chymotrypsin C (caldecrin) promotes degradation of human cationic trypsin: Identity with Rinderknecht's enzyme Y. Proc. Natl. Acad. Sci. USA 104: 11227-11232 [Abstract] [Full Text]  
• Szmola, R., Kukor, Z., Sahin-Toth, M. (2003). Human Mesotrypsin Is a Unique Digestive Protease Specialized for the Degradation of Trypsin Inhibitors. J. Biol. Chem. 278: 48580-48589 [Abstract] [Full Text]  
• Kukor, Z., Toth, M., Pal, G., Sahin-Toth, M. (2002). Human Cationic Trypsinogen. Arg117 IS THE REACTIVE SITE OF AN INHIBITORY SURFACE LOOP THAT CONTROLS SPONTANEOUS ZYMOGEN ACTIVATION. J. Biol. Chem. 277: 6111-6117 [Abstract] [Full Text]  
• Nyaruhucha, C. N.M., Kito, M., Fukuoka, S.-I. (1997). Identification and Expression of the cDNA-encoding Human Mesotrypsin(ogen), an Isoform of Trypsin with Inhibitor Resistance. J. Biol. Chem. 272: 10573-10578 [Abstract] [Full Text]  
• Szilagyi, L., Kenesi, E., Katona, G., Kaslik, G., Juhasz, G., Graf, L. (2001). Comparative in Vitro Studies on Native and Recombinant Human Cationic Trypsins. CATHEPSIN B IS A POSSIBLE PATHOLOGICAL ACTIVATOR OF TRYPSINOGEN IN PANCREATITIS. J. Biol. Chem. 276: 24574-24580 [Abstract] [Full Text]